Company Profiles

driven by the PitchBook Platform

Adicet Bio

Description

Developer of next-generation cell immunotherapies designed to treat cancer. The company's next-generation cell immunotherapies are T-Cell Receptor like antibodies with high affinity and specificity to disease-specific intracellular peptides presented on the cell surface by the major histocompatibility complex, enabling physicians to identify and validate novel disease-specific peptide targets.

2014

Founded

PRIVATE

Status

1-10

Employees

Series A

Latest Deal Type

$51M

Latest Deal Amount

$51M

Total Amount Raised

Description

Developer of next-generation cell immunotherapies designed to treat cancer. The company's next-generation cell immunotherapies are T-Cell Receptor like antibodies with high affinity and specificity to disease-specific intracellular peptides presented on the cell surface by the major histocompatibility complex, enabling physicians to identify and validate novel disease-specific peptide targets.

Website:

www.adicetbio.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

200 Constitution Drive Menlo Park, CA 94025United States +1 (310) 990-3832
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Adicet Bio's full profile, request a free trial.

    Adicet Bio Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Adicet Bio Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Adicet Bio Investors (4)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    JLABSAccelerator/Incubator000 0000000 0000
    Novartis Venture FundCorporate Venture CapitalMinority000 0000000 0000
    OrbiMedVenture CapitalMinority000 0000000 0000
    Pontifax Venture CapitalVenture CapitalMinority000 0000000 0000
    JLABS Accelerator/Incubator
    Novartis Venture Fund Corporate Venture Capital
    OrbiMed Venture Capital
    Pontifax Venture Capital Venture Capital

    Adicet Bio Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Aya Jakobovits Ph.DFounder, Chief Executive Officer, President and Board Member
    Anne Altmeyer Ph.DChief Business Officer
    Andy Lin Ph.DVice President, Product Sciences
    Aya Jakobovits Ph.D Founder, Chief Executive Officer, President and Board Member
    Anne Altmeyer Ph.D Chief Business Officer
    Andy Lin Ph.D Vice President, Product Sciences

    Adicet Bio Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Carl GordonAdicet BioBoard Member000 0000
    Erez ChimovitsOrbiMedSenior Managing Director000 0000
    Florent GrosNovartis Venture FundCo-Managing Director000 0000
    Jonathan SilversteinAdicet BioBoard Member000 0000
    Carl Gordon Board Member Adicet Bio
    Erez Chimovits Senior Managing Director OrbiMed
    Florent Gros Co-Managing Director Novartis Venture Fund
    Jonathan Silverstein Board Member Adicet Bio
    Request full access to PitchBook